» Articles » PMID: 20837534

Systemic Gut Microbial Modulation of Bile Acid Metabolism in Host Tissue Compartments

Overview
Specialty Science
Date 2010 Sep 15
PMID 20837534
Citations 337
Authors
Affiliations
Soon will be listed here.
Abstract

We elucidate the detailed effects of gut microbial depletion on the bile acid sub-metabolome of multiple body compartments (liver, kidney, heart, and blood plasma) in rats. We use a targeted ultra-performance liquid chromatography with time of flight mass-spectrometry assay to characterize the differential primary and secondary bile acid profiles in each tissue and show a major increase in the proportion of taurine-conjugated bile acids in germ-free (GF) and antibiotic (streptomycin/penicillin)-treated rats. Although conjugated bile acids dominate the hepatic profile (97.0 ± 1.5%) of conventional animals, unconjugated bile acids comprise the largest proportion of the total measured bile acid profile in kidney (60.0 ± 10.4%) and heart (53.0 ± 18.5%) tissues. In contrast, in the GF animal, taurine-conjugated bile acids (especially taurocholic acid and tauro-β-muricholic acid) dominated the bile acid profiles (liver: 96.0 ± 14.5%; kidney: 96 ± 1%; heart: 93 ± 1%; plasma: 93.0 ± 2.3%), with unconjugated and glycine-conjugated species representing a small proportion of the profile. Higher free taurine levels were found in GF livers compared with the conventional liver (5.1-fold; P < 0.001). Bile acid diversity was also lower in GF and antibiotic-treated tissues compared with conventional animals. Because bile acids perform important signaling functions, it is clear that these chemical communication networks are strongly influenced by microbial activities or modulation, as evidenced by farnesoid X receptor-regulated pathway transcripts. The presence of specific microbial bile acid co-metabolite patterns in peripheral tissues (including heart and kidney) implies a broader signaling role for these compounds and emphasizes the extent of symbiotic microbial influences in mammalian homeostasis.

Citing Articles

Deciphering the coordinated roles of the host genome, duodenal mucosal genes, and microbiota in regulating complex traits in chickens.

Lan F, Wang X, Zhou Q, Li X, Jin J, Zhang W Microbiome. 2025; 13(1):62.

PMID: 40025569 PMC: 11871680. DOI: 10.1186/s40168-025-02054-5.


Targeted Plasma Bile Acid Metabolomic Analysis in Metabolic Dysfunction-Associated Steatohepatitis and Alcoholic Hepatitis.

Hirata Y, Sakuma Y, Ogiso H, Nagai R, Aizawa K Biomedicines. 2025; 13(1).

PMID: 39857662 PMC: 11762544. DOI: 10.3390/biomedicines13010078.


Medication use is associated with distinct microbial features in anxiety and depression.

Dilmore A, Kuplicki R, McDonald D, Kumar M, Estaki M, Youngblut N Mol Psychiatry. 2025; .

PMID: 39794490 DOI: 10.1038/s41380-024-02857-2.


A gut microbiota-independent mechanism shapes the bile acid pool in mice with MASH.

Gillard J, Roumain M, Picalausa C, Thibaut M, Clerbaux L, Tailleux A JHEP Rep. 2025; 6(11):101148.

PMID: 39741697 PMC: 11686050. DOI: 10.1016/j.jhepr.2024.101148.


Exposing 24-hour cycles in bile acids of male humans.

Bello A, Sarafian M, Wimborne E, Middleton B, Revell V, Raynaud F Nat Commun. 2024; 15(1):10014.

PMID: 39562795 PMC: 11576969. DOI: 10.1038/s41467-024-53673-9.


References
1.
Turnbaugh P, Ley R, Mahowald M, Magrini V, Mardis E, Gordon J . An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006; 444(7122):1027-31. DOI: 10.1038/nature05414. View

2.
Claus S, Tsang T, Wang Y, Cloarec O, Skordi E, Martin F . Systemic multicompartmental effects of the gut microbiome on mouse metabolic phenotypes. Mol Syst Biol. 2008; 4:219. PMC: 2583082. DOI: 10.1038/msb.2008.56. View

3.
Ley R, Turnbaugh P, Klein S, Gordon J . Microbial ecology: human gut microbes associated with obesity. Nature. 2006; 444(7122):1022-3. DOI: 10.1038/4441022a. View

4.
Craig A, Sidaway J, Holmes E, Orton T, Jackson D, Rowlinson R . Systems toxicology: integrated genomic, proteomic and metabonomic analysis of methapyrilene induced hepatotoxicity in the rat. J Proteome Res. 2006; 5(7):1586-601. DOI: 10.1021/pr0503376. View

5.
Watanabe M, Houten S, Wang L, Moschetta A, Mangelsdorf D, Heyman R . Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c. J Clin Invest. 2004; 113(10):1408-18. PMC: 406532. DOI: 10.1172/JCI21025. View